Advanced Micro Devices Inc. (NASDAQ: AMD) has a PC problem, the same one Intel Corp. flagged days ago: higher memory costs are reducing demand. Even so, AMD shares rose about 5% in after-hours trading ...
Recursive, an AI startup founded last year, is starting to live up to its name. The company, which is trying to build AI that can improve itself, released its first model, Flint, on Wednesday. Flint ...
Flint launched on October 21, 2026. It is a 40-billion-parameter model built specifically for coding work. On a MacBook Pro with an M4 Pro chip, Flint generates over 125 tokens per second. On RTX ...
For the past few days I’ve been testing an impressive open-weight AI coding model called Flint. It suggests that fully recursive self-improvement, or RSI—an exciting and controversial approach that ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
The stock of Recursion Pharmaceuticals (RXRX) has gained >15% in early trading today, as the AI-driven drug discovery company shared a couple of notable updates. Firstly Recursion announced the ...
In March of 2026, the FDA finalized a rule requiring Big Pharma and startups alike to switch to a uniform 12-digit code by 2033. While it may appear to be a routine regulatory update, the change ...
This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Regan Peng is an AI founder and former senior tech executive, focused on personal AI, ...
“Recursive self-improvement” is the idea that artificial intelligence could learn to build and train itself, creating exponential new progress — and risk. Jeff Clune, a computer scientist and ...
How do you get from a chatbot that sometimes makes things up to a machine that humans might struggle to control? There are several steps in that argument, and plenty of uncertainty. But an idea known ...
U.S. investors could soon get the chance to pile into a pure-play robotics company that said it just achieved a big breakthrough in the world of humanoids — as it seeks to improve its financial ...
Recursion Pharmaceuticals, Inc. remains a Hold as competitive advances and slow revenue growth challenge its AI-driven drug discovery ambitions. RXRX's partnerships, notably with Genentech/Roche and ...